| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
|
APOE
|
apolipoprotein E
|
|
APOL1
|
apolipoprotein L, 1
|
|
AR
|
androgen receptor
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ATXN7
|
ataxin 7
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CBR3
|
carbonyl reductase 3
|
|
CCL4L1
|
chemokine (C-C motif) ligand 4-like 1
|
|
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD28
|
CD28 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
COMT
|
catechol-O-methyltransferase
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CRH
|
corticotropin releasing hormone
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11
|
|
DRD2
|
dopamine receptor D2
|
|
EDN1
|
endothelin 1
|
|
EDNRB
|
endothelin receptor type B
|
|
EGFR
|
epidermal growth factor receptor
|
|
EPOR
|
erythropoietin receptor
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FGB
|
fibrinogen beta chain
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GRK4
|
G protein-coupled receptor kinase 4
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
KCNS1
|
potassium voltage-gated channel, modifier subfamily S, member 1
|
|
LCT
|
lactase
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LIPC
|
lipase, hepatic
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPPB
|
natriuretic peptide B
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PGR
|
progesterone receptor
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPP3R1
|
protein phosphatase 3, regulatory subunit B, alpha
|
|
PRSS8
|
protease, serine, 8
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PYY
|
peptide YY
|
|
RARB
|
retinoic acid receptor, beta
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SULT2A1
|
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
TRBV18
|
T cell receptor beta variable 18
|
|
TRBV3-1
|
T cell receptor beta variable 3-1
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
